Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension

被引：20
|
作者：
Anthi, Anastasia [1 ,2 ]
Tsangaris, Iraklis [1 ,2 ]
Hamodraka, Eftichia S. [3 ]
Lekakis, John [2 ,3 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Crit Care 2, Attikon Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Pulm Hypertens Clin, Attikon Gen Hosp, GR-11527 Athens, Greece
[3] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, GR-11527 Athens, Greece
来源：
BLOOD | 2012年 / 120卷 / 07期
关键词：
SICKLE-CELL-DISEASE; SILDENAFIL;
D O I：
10.1182/blood-2012-04-422568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1531 / 1532
页数：4
相关论文
共 50 条
  • [1] Bosentan for the treatment of pulmonary arterial hypertension
    Kenyon, KW
    Nappi, JM
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (7-8) : 1055 - 1062
  • [2] Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
    Valerio, Christopher J.
    Coghlan, John G.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 607 - 619
  • [3] Treatment of pulmonary hypertension in three patients with β-thalassemia intermedia using pulmonary arterial hypertension-specific medications
    Gerede, Demet Menekse
    Acibuca, Aynur
    Sayin, Tamer
    Erol, Cetin
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (01): : 64 - 66
  • [4] Bosentan. Role in the treatment of pulmonary arterial hypertension
    Carlos Grignola, Juan
    Gomez Sanchez, Miguel Angel
    [J]. INSUFICIENCIA CARDIACA, 2009, 4 (01) : 11 - 22
  • [5] Mildly symptomatic pulmonary arterial Hypertension Treatment with Bosentan?
    Halank, M.
    [J]. PNEUMOLOGE, 2009, 6 (01): : 35 - +
  • [6] Bosentan, hope or reality for the treatment of pulmonary arterial hypertension
    Rubio, JLC
    Centeno, NO
    Martinez, MNB
    Torres-Pujol, JMDH
    [J]. MEDICINA CLINICA, 2004, 123 (04): : 158 - 159
  • [7] Bosentan: A novel agent for the treatment of pulmonary arterial hypertension
    O'Callaghan, D
    Gaine, SP
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (01) : 69 - 73
  • [8] Bosentan for the treatment of pulmonary arterial hypertension associated to scleroderma
    Hachulla, E.
    Launay, D.
    Humbert, M.
    [J]. REVUE DE MEDECINE INTERNE, 2007, 28 : S221 - S226
  • [9] PULMONARY ARTERIAL HYPERTENSION IN β-THALASSEMIA MAJOR PATIENTS: SYMPTOM & QUALITY OF LIFE IMROVEMENT AFTER TREATMENT WITH BOSENTAN
    Farmaki, K.
    Kolymbianaki, P.
    Tzoumari, I.
    Pappa, C.
    Kariofillis, P.
    Voudris, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 765 - 765
  • [10] Response of patients with pulmonary arterial hypertension that do not qualify for treatment with bosentan to treatment with bosentan
    Bshouty, Z
    [J]. CHEST, 2005, 128 (04) : 367S - 367S
12345